National HIV prevalence surveillance among TB patients through periodic surveys: Experience in Cambodia

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 3 SUPPL. 1, 2008, Pages

  Tamura, M ^a,b   Eam, K K ^c   Kimura, K ^b   Yoshihara, N ^a,b   Miura, T ^a   Yanai, H ^b   Yamada, N ^b   Jayavanth, P ^d   Van Maaren, P ^d   Okada, K ^a,b   Onozaki, Ikushi ^a,b   Eang, M T ^c  

^a JAPAN INTERNATIONAL COOPERATION AGENCY   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^c CENAT   (Cambodia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Cambodia; Surveillance; TB HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CAMBODIA; CHILD; CONTROLLED STUDY; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; RATING SCALE; SEROPREVALENCE; SMEAR; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CAMBODIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PREVALENCE; TUBERCULOSIS;

EID: 40549116631     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. World Health Organization. WHO report 2007. Global tuberculosis control surveillance, planning, financing. WHO/HTM/TB/2007.376. Geneva, Switzerland: WHO, 2007.
2. National Centre for Tuberculosis and Leprosy Control. Report of the National TB Prevalence Survey, 2002. Phnom Penh, Cambodia: CENAT, 2005.
3. Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO epidemiological fact sheets on HIV/AIDS and sexually transmitted infections 2004 update. Geneva, Switzerland: UNAIDS, 2004. http://data.unaids.org/Publications/Fact-Sheets01/ cambodia_EN.pdf Accessed December 2007.
4. National Centre for HIV/AIDS, Dermatology and STDs. HIV Sentinel Surveillance 2003: results, trends, and estimates. Phnom Penh, Cambodia: NCHADS, 2003. http://www.nchads.org/Doc/dissemination/HSS2003_Eng.pdf Accessed December 2007.
5. Yanai H, Uthaivoravit W, Panich V, et al. Rapid increase in HIV-related tuberculosis, Chiang Rai, Thailand, 1990-1994. AIDS 1996; 10: 527-531.
6. Quy H T, Nhien D T, Lan N T, Borgdorff M W, Broekmans J F. Steep increase in HIV prevalence among tuberculosis patients in Ho Chi Minh City. AIDS 2002; 16: 931-932.
7. National Centre for HIV/AIDS, Dermatology, and STDs. Report on HIV Sentinel Surveillance in Cambodia 2002. Phnom Penh, Cambodia; NCHADS, 2002.
8. World Health Organization. Guidelines for HIV surveillance among tuberculosis patients. 2nd ed. WHO/HTM/TB/2004. 339. Geneva, Switzerland: WHO, 2004.
9. World Health Organization. Guidelines for HIV surveillance among tuberculosis patients. WHO/TB/94.180. Geneva, Switzerland: WHO, 1994.
10. World Health Organization. TB/HIV: a clinical manual. 2nd ed. WHO/HTM/TB/2004.3.29. Geneva, Switzerland: WHO, 2004.
11. National Centre for Tuberculosis and Leprosy Control. Tuberculosis report 2002. Phnom Penh, Cambodia: CENAT, 2004.
12. World Health Organization. Summary country profile for HIV/AIDS treatment scale-up. Geneva, Switzerland: WHO, 2005. http://www.who.int/3by5/support/ june2005_khm.pdf.
13. National Centre for HIV/AIDS, Dermatology, and STDs. Comprehensive report on HIV/AIDS in Cambodia year 2005. Phnom Penh, Cambodia: NCHADS, 2005.
14. Wiktor S Z, Sassan-Morokro M, Grant A D, et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire; a randomised controlled trial. Lancet 1999; 353: 1469-1475.
15. Mwaungulu F B, Floyd S, Crampin A C, et al. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ 2004; 82: 354-363.
16. Siriarayapon P, Yanai H, Glynn J R, et al. The evolving epidemiology of HIV infection and tuberculosis in Northern Thailand. J Acquir Immune Defic Syndr 2002; 31: 80-89.
17. Tamura M, Khun K E, Yuos B H, et al. High prevalence/incidence of TB and poor outcomes of TB treatment among people living with HIV/AIDS (PLWHA) in Phnom Penh, Cambodia. Bangkok, Thailand: XV International AIDS Conference. Int Conf AIDS 2004; 15: abstract no. B11140.
18. Centres for Disease Control and Prevention. Screening HIV-infected persons for tuberculosis - Cambodia, January 2004-February 2005. MMWR Morb Mortal Wkly Rep. 2005; 54: 1177-1178.
19. Abouya L, Coulibaly I S, Wiktor S Z, et al. The Cote d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data. AIDS 1998; 12: 505-512.
20. Libamba E, Makombe S, Harries A D, et al. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes - the case of Malawi. Int J Tuberc Lung Dis 2005; 9: 1062-1071.
21. Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med 2005; 172: 123-127.
22. Deriemer K, Soares E C, Dias S M, Cavalcante S C. HIV testing among tuberculosis patients in the era of antiretroviral therapy: a population-based study in Brazil. Int J Tuberc Lung Dis 2000; 4: 519-527.
23. Koening S P, Leandre F, Farmer P E. Scaling-up HIV treatment programmes in a resource-limited setting: the rural Haiti experience. AIDS 2004; 18 (Suppl): S21-S25.